Global Infant Phototherapy Devices Market Size & Share Analysis Report 2024-2032

  • The global infant phototherapy devices market size reached USD 89.4 Million in 2023.
  • The market is expected to reach USD 123.2 Million by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032.
  • Region-wise the market has been segmented into North America (United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa.
  • Based on the light source, the market has been divided into fluorescent lamps (FL), light-emitting diodes (LEDs), quartz halogen lamps, and gas discharge tubes.
  • On the basis of configuration, the market has been bifurcated into mobile device and fixed device.
  • Based on the end user, the market has been classified into hospital and neonatal clinics.
  • The rising prevalence of neonatal jaundice across the globe is a primary driver of the infant phototherapy devices market.
  • Technological advancements and improved healthcare infrastructure are reshaping the infant phototherapy devices market.

Request to Get the Sample Report: https://www.imarcgroup.com/infant-phototherapy-devices-market/requestsample

Industry Trends and Drivers:

  • Growing Prevalence of Neonatal Jaundice:

The increasing incidence of neonatal jaundice is a primary factor driving the infant phototherapy devices market growth. This condition, characterized by elevated bilirubin levels causing yellowing of the skin and eyes, is common among newborns, particularly in the first few days of life. If untreated, severe cases can lead to complications, such as kernicterus, a form of brain damage.

Consequently, healthcare providers emphasize early diagnosis and treatment to mitigate these risks, thereby increasing the reliance on phototherapy devices as an effective and non-invasive treatment. Phototherapy works by using light to alter bilirubin molecules, making it easier for an infant’s body to eliminate them naturally. Hospitals and clinics invest heavily in phototherapy equipment to manage the large number of newborns who develop jaundice, and these trends are evident globally.

  • Improved Healthcare Infrastructure:

The enhancement of healthcare infrastructure, particularly in emerging economies, has significantly contributed to the market share. Many developing nations have recognized the importance of investing in neonatal care, especially as infant mortality rates remain a public health concern. Improvements in hospital facilities and the availability of specialized neonatal units allow healthcare providers to incorporate phototherapy as a standard treatment option for neonatal jaundice.

Moreover, as healthcare systems evolve, there is an increased emphasis on equipping facilities with advanced medical technology, including phototherapy devices, to ensure quality care for newborns. Access to phototherapy devices has been further bolstered by government policies focused on reducing neonatal mortality and morbidity rates.

  • Technological Advancements:

The infant phototherapy devices market size has benefitted significantly from technological advancements, particularly the shift from traditional fluorescent lamps to light-emitting diode (LED)-based devices. LED phototherapy devices are energy-efficient, emit less heat, and provide consistent, high-intensity light that enhances the efficacy of treatment. Compared to conventional phototherapy lamps that need frequent replacement, LED devices have a longer lifespan, reducing operational costs and downtime in healthcare settings.

Additionally, they are more compact, making them easier to integrate into neonatal units with limited space. LEDs also allow for customized wavelength emission, optimizing bilirubin breakdown and ensuring that the infant receives safe and effective treatment. These innovations have made LED phototherapy devices a preferred choice for healthcare providers seeking reliable and cost-effective treatment solutions.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=4728&flag=C

Infant Phototherapy Devices Market Report Segmentation:

Breakup By Light Source:

  • Fluorescent Lamps (FL)
  • Light-Emitting Diodes (LEDs)
  • Quartz Halogen Lamps
  • Gas Discharge Tubes

Based on the light source, the market has been divided into fluorescent lamps (FL), light-emitting diodes (LEDs), quartz halogen lamps, and gas discharge tubes.

Breakup By Configuration:

  • Mobile Device
  • Fixed Device

On the basis of configuration, the market has been bifurcated into mobile device and fixed device.

Breakup By End User:

  • Hospital
  • Neonatal Clinics

Based on the end user, the market has been classified into hospital and neonatal clinics.

Breakup By Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Region-wise the market has been segmented into North America (United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa.

Top Infant Phototherapy Devices Market Leaders: The infant phototherapy devices market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.

Some of the key players in the market are:

  • Atom Medical Corporation
  • AVI Healthcare Private Limited
  • Equalize Health
  • General Electric Company
  • Ibis Medical Equipment and Systems Pvt Ltd
  • Natus Medical Incorporated
  • Ningbo David Medical Device Company Limited
  • NOVOS Medical Systems
  • Weyer GmbH
  • Zhengzhou Dison Instrument
  • Meter Co. Ltd.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1–631–791–1145